UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10026
Bancreek US Large Cap ETF
BCUS
$142M
| $74 | ﹤0.01% |
2
| – | – |
2024 Q3
7 quarters
|
|
10027
Lulu's Fashion Lounge
LVLU
$31M
| $74 | ﹤0.01% |
9
-1,911
| -100% | -$17.6K |
2021 Q4
18 quarters
|
|
10028
Rising Dragon Acquisition Corp Rights
RDACR
| $74 | ﹤0.01% |
+1,062
| New | +$124 |
2026 Q2
0 quarters
|
|
10029
Biodexa Pharmaceuticals
BDRX
$741K
| $73 | ﹤0.01% |
3
| – | – |
2023 Q4
10 quarters
|
|
10030
Millennium Group International
MGIH
$15.8M
| $73 | ﹤0.01% |
+49
| New | +$73 |
2026 Q2
0 quarters
|
|
10031
NeuroSense Therapeutics Warrant
NRSNW
$17.5K
| $73 | ﹤0.01% |
1,163
| – | – |
2024 Q2
8 quarters
|
|
10032
Siddhi Acquisition Corp
SDHI
$369M
| $73 | ﹤0.01% |
+7
| New | +$73 |
2026 Q2
0 quarters
|
|
10033
Pioneer Acquisition I Corp
PACH
$295M
| $72 | ﹤0.01% |
7
-9,053
| -100% | -$92.4K |
2026 Q1
1 quarter
|
|
|
OSRHW
10034
DELISTED
OSR Health Warrant
OSRHW
| $71 | ﹤0.01% |
+1,347
| New | +$75 |
2026 Q2
0 quarters
|
|
|
NXTI
10035
DELISTED
Simplify Next Intangible Core Index ETF
NXTI
| $70 | ﹤0.01% |
+2
| New | +$65 |
2026 Q2
0 quarters
|
|
10036
MOZAYYX Acquisition Corp Warrants
MZYX.WS
| $70 | ﹤0.01% |
+100
| New | +$46 |
2026 Q2
0 quarters
|
|
10037
OneMedNet Corp Warrant
ONMDW
$350K
| $69 | ﹤0.01% |
1,984
-700
| -26% | -$29 |
2026 Q1
1 quarter
|
|
10038
ProShares Ultra Real Estate
URE
$56.8M
| $69 | ﹤0.01% |
1
| – | – |
2024 Q2
8 quarters
|
|
|
DVXC
10039
DELISTED
WEBs Communication Services XLC Defined Volatility ETF
DVXC
| $69 | ﹤0.01% |
3
| – | – |
2025 Q4
2 quarters
|
|
10040
Black Titan Corp
BTTC
$4.78M
| $69 | ﹤0.01% |
92
+43
| +88% | +$49 |
2025 Q4
2 quarters
|
|
10041
Direxion Daily NVDA Bear 1X ETF
NVDD
$19.5M
| $68 | ﹤0.01% |
2
| – | – |
2025 Q1
5 quarters
|
|
10042
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$92.7K
| $67 | ﹤0.01% |
5,561
| – | – |
2025 Q1
5 quarters
|
|
10043
THOR Low Volatility ETF
THLV
$56M
| $67 | ﹤0.01% |
+2
| New | +$65 |
2026 Q2
0 quarters
|
|
10044
Planet Green Holdings
PLAG
$5.25M
| $64 | ﹤0.01% |
29
-3,523
| -99% | -$5.78K |
2026 Q1
1 quarter
|
|
10045
Primech Holdings
PMEC
$11.6M
| $64 | ﹤0.01% |
100
-1,359
| -93% | -$952 |
2025 Q1
5 quarters
|
|
10046
rYojbaba Co Ltd
RYOJ
$30.6M
| $64 | ﹤0.01% |
25
-4,313
| -99% | -$10.7K |
2025 Q3
3 quarters
|
|
10047
CCSC Technology International Holdings
CCTG
$4.02M
| $62 | ﹤0.01% |
81
-6,465
| -99% | -$4.11K |
2024 Q2
8 quarters
|
|
10048
Starry Sea Acquisition Corp
SSEA
| $62 | ﹤0.01% |
+6
| New | +$61 |
2026 Q2
0 quarters
|
|
10049
General Catalyst Global Resilience Merger Corp Units
GCGRU
| $62 | ﹤0.01% |
+6
| New | +$61 |
2026 Q2
0 quarters
|
|
10050
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$175M
| $61 | ﹤0.01% |
2
-4,328
| -100% | -$159K |
2021 Q2
20 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.